PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Immunoassay clinical analyzers • Immunoassay analyzers PART 07: Market segmentation by application • Immunoassay analyzer market in oncology and endocrinology in the US • Hepatitis and retrovirus testing in US • Infectious disease testing market in the US • GI stool testing market in the US PART 08: Market segmentation by product • Instruments • Services and spare parts PART 09: Market drivers • Attractive venture capital for SMEs • Rising demand for next-generation immunodiagnostics • Focus on partnerships and acquisitions for product development • Focus on disease management PART 10: Impact of drivers PART 11: Market challenges • Limited detection capability and complexity • High cost of upgrading • Reimbursement limitations PART 12: Impact of drivers and challenges PART 13: Market trends • Paper-based electrochemical immunoassay devices • Requirement of LFI by the US Army • Government programs for biomarker-based cancer detection PART 14: Vendor landscape • Competitive scenario • Abbott Diagnostics • Beckman Coulter • bioMérieux • Roche Diagnostics • Siemens Healthcare Diagnostics • Other prominent vendors PART 15: Key vendor analysis • Abbott Diagnostics • Beckman Coulter • bioMérieux • Roche Diagnostics • Siemens Healthcare PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Clinical immunoassay analyzer market in the US 2015-2020 ($ billions) Exhibit 03: Five forces analysis Exhibit 04: Price comparison of single agent, multiple agents, and automated immunoassay systems Exhibit 05: Segmentation of clinical immunoassay analyzer market in the US based on application Exhibit 06: Immunoassay analyzer market in oncology and endocrinology in the US 2015-2020 ($ millions) Exhibit 07: Hepatitis and retrovirus testing market in the US 2015-2020 ($ millions) Exhibit 08: Infectious disease testing market in the US 2015-2020 ($ millions) Exhibit 09: GI stool testing market in the US 2015-2020 ($ millions) Exhibit 10: Segmentation of clinical immunoassay analyzer market by application 2015 Exhibit 11: Clinical immunoassay analyzer market based on product 2015 Exhibit 12: Impact of drivers Exhibit 13: Impact of drivers and challenges Exhibit 14: Key takeaways: Abbott Diagnostics Exhibit 15: Key takeaways: Beckman Coulter Exhibit 16: Key takeaways: bioMérieux Exhibit 17: Key takeaways: Roche Diagnostics Exhibit 18: Key takeaways: Siemens Healthcare Diagnostics Exhibit 19: Abbott Diagnostics: Key business offerings Exhibit 20: Beckman Coulter: Business segmentation Exhibit 21: bioMérieux: Applications by technology Exhibit 22: Roche Diagnostics: Business segmentation by revenue 2014 Exhibit 23: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 24: Roche Diagnostics: Geographical segmentation by revenue 2014 Exhibit 25: Siemens Healthcare: Geographical segmentation by revenue 2014

Abbott Diagnostics, Beckman Coulter, bioMérieux, Roche Diagnostics, Siemens Healthcare Diagnostics, Affimetrix, Boditech Med, DiaSorin, DRG International, Enzo Life Sciences, EMD Millipore, Immunodiagnostics System, Inova Diagnostics, Meso Scale Discovery, Nova Century Scientific, Olympus, Quidel, Radiometer, Randox Laboratories, SDIX, Tecan, Thermo Fisher Scientific.